M. I. Colnaghi

A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.

Sabina Carla Righetti, Gabriella Della Torre, S. Pilotti et al. · PubMed · 1996 · 281 citations

Medicine, Gynecology, Oncology +16

Regression of Advanced Ovarian Carcinoma by Intraperitoneal Treatment With Autologous TLymphocytes Retargeted by a Bispecific Monoclonal Antibody

Silvana Canevari, Gerrit Stoter, Flavio Arienti et al. · JNCI Journal of the National Cancer Institute · 1995 · 191 citations

Life Sciences, Immunology, Oncology +15

The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage.

Serenella M. Pupa, Sylvie Ménard, Daniele Morelli et al. · PubMed · 1993 · 154 citations

Medicine, Molecular Biology, Oncology +11

Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19

L. Mantovani, Silvia Miotti, Sylvie Ménard et al. · European Journal of Cancer · 1994 · 122 citations

Medicine, Biochemistry, Oncology +12

Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients.

Serenella M. Pupa, Sylvie Ménard, Salvatore Andreola et al. · PubMed · 1993 · 105 citations

Medicine, Immunology, Oncology +16